MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$1,108,657
Unrealized gain on
short-term debt...
$1,781
Net loss
-$1,110,438
Interest and dividend
income, net
$44,604
Loss before
provision for income taxes
-$1,110,438
Total other income,
net
$41,028
Unrealized loss on crypto
assets
$2,690
Interest expense
$886
Loss from operations
-$1,151,466
Total operating
expenses
$1,148,804
Gross profit (loss)
-$2,662
License fee revenue
$18,025
Research and development
$543,615
Professional fees
$313,194
Compensation expense
$227,132
Other selling,
general and...
$64,863
Cost of revenues
$20,687
Back
Back
Income Statement
source: myfinsight.com
Silo Pharma, Inc. (SILO)
Silo Pharma, Inc. (SILO)